Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 16, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 January 2026 - 14:12

Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 16, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/daptomycin-hospira

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters